Common Stock, Shares, Outstanding of Finch Therapeutics Group, Inc. from 31 Dec 2020 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Finch Therapeutics Group, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Jun 2024.
  • Finch Therapeutics Group, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2024 was 1,605,763, a 0.06% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Finch Therapeutics Group, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 1,605,763 +1,002 +0.06% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 1,605,763 -46,539,161 -97% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 1,605,763 +4,046 +0.25% 31 Dec 2023 10-Q 13 Aug 2024 2024 Q2
Q3 2023 1,605,034 -46,221,472 -97% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 1,604,761 -46,080,952 -97% 30 Jun 2023 10-Q/A 11 Aug 2023 2023 Q2
Q1 2023 48,144,924 +612,336 +1.3% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 1,601,717 -45,910,465 -97% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 47,826,506 +371,544 +0.78% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 47,685,713 +259,961 +0.55% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 47,532,588 +305,285 +0.65% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 47,512,182 +39,120,389 +466% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 47,454,962 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 47,425,752 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 47,227,303 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 8,391,793 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.